Concepedia

Karenza Alexis

KA

Statistics

Publications

11

Citations

434

H-Index

11

Active since

2003

Affiliations

Affimed Therapeutics (Germany)(Current)

Eisai (United States)

The University of Texas MD Anderson Cancer Center

Vall d'Hebron Institute of Oncology

Jacobi Medical Center

Karenza Alexis is an author at Affimed Therapeutics (Germany) specializing in medicine, immunology, and pathology.

ORCID

Top concepts

Publications per year

2003–2023

11

Publications

11

Ethnic Neutropenia and Treatment Delay in African American Women Undergoing Chemotherapy for Early-Stage Breast Cancer

Dawn L. Hershman, Mitchell Weinberg, Zachary Rosner et al. · JNCI Journal of the National Cancer Institute · 2003 · 154 citations

36-Year-Old Female with Catastrophic Antiphospholipid Syndrome Treated with Eculizumab: A Case Report and Review of Literature

Marianna Strakhan, Mariana Hurtado-Sbordoni, Nahun Galeas et al. · Case Reports in Hematology · 2014 · 85 citations · Full text

, , +20

High absolute lymphocyte counts are associated with longer overall survival in patients with metastatic breast cancer treated with eribulin—but not with treatment of physician’s choice—in the EMBRACE study

Yasuo Miyoshi, Yuta Yoshimura, Kenichi Saito et al. · Breast Cancer · 2020 · 72 citations · Full text

Innate Cell Engager AFM13 Combined with Preactivated and Expanded Cord Blood-Derived NK Cells for Patients with Double Refractory CD30+ Lymphoma

Yago Nieto, Pinaki P. Banerjee, Indreshpal Kaur et al. · Blood · 2022 · 23 citations

Innate Cell Engager (ICE®) AFM13 Combined with Preactivated and Expanded (P+E) Cord Blood (CB)-Derived Natural Killer (NK) Cells for Patients with Refractory CD30-Positive Lymphomas: Final Results

Yago Nieto, Pinaki P. Banerjee, Indreshpal Kaur et al. · Blood · 2023 · 19 citations

1–5 of 11